ARDS

  • coronavirus

    Glaucoma drug studied to prevent lung Infection in COVID-19 patients

    Vanderbilt University Medical Center is evaluating razuprotafib, a drug used to treat glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19. Read More

    Jun 24, 2020

  • Vanderbilt University

    American College of Critical Care Medicine honors Bernard

    Gordon Bernard, M.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC), will receive the American College of Critical Care Medicine’s highest honor, the Distinguished Investigator Award, during the Society of Critical Care Medicine’s (SCCM) 46th Critical Care Congress in Honolulu in January, 2017. Read More

    Sep 29, 2016